Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Mario Scartozzi

1-50 of 126 results

View this query on the Wikidata Query Service
PTEN expression and KRAS mutations on primary tumors and metastases in the prediction of benefit from cetuximab plus irinotecan for patients with metastatic colorectal cancer

scientific article published on 27 April 2009
Arterial hypertension correlates with clinical outcome in colorectal cancer patients treated with first-line bevacizumab

scientific article
Epidermal growth factor receptor (EGFR) status in primary colorectal tumors does not correlate with EGFR expression in related metastatic sites: implications for treatment with EGFR-targeted monoclonal antibodies.

scientific article published in December 2004
Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients

scientific article published on February 7, 2012
Nuclear Factor-kB Tumor Expression Predicts Response and Survival in Irinotecan-Refractory Metastatic Colorectal Cancer Treated With Cetuximab-Irinotecan Therapy

article
Cetuximab plus gemcitabine and cisplatin compared with gemcitabine and cisplatin alone in patients with advanced pancreatic cancer: a randomised, multicentre, phase II trial

scientific article published in January 2008
Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?

scientific article published on 5 March 2012
VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study

scientific article published on 20 February 2014
Epidermal Growth Factor Receptor (EGFR) gene copy number (GCN) correlates with clinical activity of irinotecan-cetuximab in K-RAS wild-type colorectal cancer: a fluorescence in situ (FISH) and chromogenic in situ hybridization (CISH) analysis

scientific article published on 27 August 2009
Evolving strategies for the treatment of hepatocellular carcinoma: from clinical-guided to molecularly-tailored therapeutic options.

scientific article published on 25 August 2010
Insulin-like growth factor 1 expression correlates with clinical outcome in K-RAS wild type colorectal cancer patients treated with cetuximab and irinotecan.

scientific article published in October 2010
The role of HER-3 expression in the prediction of clinical outcome for advanced colorectal cancer patients receiving irinotecan and cetuximab.

scientific article published on 6 January 2011
The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management

scientific article published on 20 February 2014
Epidermal growth factor receptor (EGFR) gene promoter methylation and cetuximab treatment in colorectal cancer patients.

scientific article
The role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatment.

scientific article published on 19 May 2014
Metronomic chemotherapy from rationale to clinical studies: a dream or reality?

scientific article published on 20 January 2015
Dalotuzumab, a recombinant humanized mAb targeted against IGFR1 for the treatment of cancer.

scientific article published on June 2010
Molecular biology of sporadic gastric cancer: prognostic indicators and novel therapeutic approaches.

scientific article published in August 2004
Profiling tumor-associated markers for early detection of malignant mesothelioma: an epidemiologic study

scientific article
Neutrophil-to-lymphocyte ratio may be associated with the outcome in patients with prostate cancer.

scientific article
5-Fluorouracil pharmacogenomics: still rocking after all these years?

scientific article published on February 2011
The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management

scientific article
Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy.

scientific article published on 21 January 2016
Mutations of hMLH1 and hMSH2 in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with microsatellite instability and abnormalities of mismatch repair protein expression

scientific article published on 01 March 2002
The value of lactate dehydrogenase serum levels as a prognostic and predictive factor for advanced pancreatic cancer patients receiving sorafenib.

scientific article published on 10 September 2015
High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of Digestive

scientific article
A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activation

scientific article published on 4 December 2007
Combined analysis of E-cadherin gene (CDH1) promoter hypermethylation and E-cadherin protein expression in patients with gastric cancer: implications for treatment with demethylating drugs.

scientific article published in March 2004
The challenge of targeted therapies for gastric cancer patients: the beginning of a long journey

scientific article published on 07 May 2014
Hepatocellular carcinoma treatment over sorafenib: epigenetics, microRNAs and microenvironment. Is there a light at the end of the tunnel?

scientific article published on 27 July 2015
Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: implications for clinical management

scientific article published on 17 August 2015
COX-2 and NF-KB overexpression is common in pancreatic cancer but does not predict for COX-2 inhibitors activity in combination with gemcitabine and oxaliplatin.

scientific article published in October 2007
Trans-arterial chemo-embolization (TACE), with either lipiodol (traditional TACE) or drug-eluting microspheres (precision TACE, pTACE) in the treatment of hepatocellular carcinoma: efficacy and safety results from a large mono-institutional analysis

scientific article
Analysis of HER-3, insulin growth factor-1, nuclear factor-kB and epidermal growth factor receptor gene copy number in the prediction of clinical outcome for K-RAS wild-type colorectal cancer patients receiving irinotecan-cetuximab.

scientific article published on 23 November 2011
Prognostic Role ofInterleukin-1βGene andInterleukin-1 Receptor AntagonistGene Polymorphisms in Patients With Advanced Gastric Cancer

article
Cancer stem cell gene profile as predictor of relapse in high risk stage II and stage III, radically resected colon cancer patients

scientific article
Molecular biomarkers of resistance to anti-EGFR treatment in metastatic colorectal cancer, from classical to innovation

scientific article published on 24 June 2013
Clinical significance and treatment of skin rash from erlotinib in non-small cell lung cancer patients: results of an Experts Panel Meeting.

scientific article
Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab

scientific article
Basal and bevacizumab-based therapy-induced changes of lactate dehydrogenases and fibrinogen levels and clinical outcome of previously untreated metastatic colorectal cancer patients: a multicentric retrospective analysis.

scientific article
Pancreatic cancer: progress in cancer therapy.

scientific article published on 19 March 2008
Toward molecularly selected chemotherapy for advanced gastric cancer: state of the art and future perspectives.

scientific article published on 20 May 2009
Prognostic impact of mismatch repair genes germline defects in colorectal cancer patients: are all mutations equal?

scientific article published on 15 October 2015
Loss of hMLH1 expression correlates with improved survival in stage III-IV ovarian cancer patients

scientific article published in May 2003
Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients

scientific article
Anemia may influence the outcome of patients undergoing neo-adjuvant treatment of rectal cancer

scientific article published on 12 September 2006
The "angiogenetic ladder", step-wise angiogenesis inhibition in metastatic colorectal cancer.

scientific article published on 20 June 2014
Natural history of malignant bone disease in hepatocellular carcinoma: final results of a multicenter bone metastasis survey.

scientific article
Novel perspectives for the treatment of gastric cancer: from a global approach to a personalized strategy.

scientific article published in May 2010
Perioperative anemia and blood transfusions as prognostic factors in patients undergoing resection for non-small cell lung cancers

scientific article published on 01 September 2005

Paulina is supported by:

About Paulina

Help